These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6433476)

  • 21. [Changes in coagulation factor VIII after liver transplantation in a patient with hemophilia A].
    Deshayes JP; Tartière J; Samba D; Auvray S; Segol P; Lequerrec A; Derlon A
    Presse Med; 1992 Feb; 21(5):216. PubMed ID: 1532088
    [No Abstract]   [Full Text] [Related]  

  • 22. Aspects of the management of hemophilia in childhood. Availability of newer concentrates of antihemophilic factor failitates management.
    Strauss HS
    R I Med J; 1966 Aug; 49(8):466-8. PubMed ID: 5222119
    [No Abstract]   [Full Text] [Related]  

  • 23. [Cryoprecipitate should have preference over factor VIII concentrate in the treatment of patients with hemophilia A].
    Kunst VA; Nováková IR; Haanen C
    Ned Tijdschr Geneeskd; 1989 Jun; 133(23):1163-6. PubMed ID: 2501689
    [No Abstract]   [Full Text] [Related]  

  • 24. [The cryoprecipitate, plasmatic fraction rich in antihemophilic globulin (factor VIII). Its use in the treatment of hemophilia].
    Otto-Servais M; Hugues J
    Rev Med Liege; 1969 May; 24(10):401-7. PubMed ID: 5376503
    [No Abstract]   [Full Text] [Related]  

  • 25. Recombinant factor VIII in hemophilia A: the Canadian experience.
    Blanchette VS
    Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S33-9. PubMed ID: 9351535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of hemorrhage in hemophilia.
    Med Lett Drugs Ther; 1967 Apr; 9(8):31-2. PubMed ID: 6040171
    [No Abstract]   [Full Text] [Related]  

  • 27. [Advances in hemophilia treatment: a hepatitis-safe factor VIII concentrate].
    Heimburger N
    Blut; 1982 Apr; 44(4):249-51. PubMed ID: 6805537
    [No Abstract]   [Full Text] [Related]  

  • 28. Factor VIII therapy for hemophilia A: current and future issues.
    Aledort L; Ljung R; Mann K; Pipe S
    Expert Rev Hematol; 2014 Jun; 7(3):373-85. PubMed ID: 24717090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Opportune treatment of hemorrhage in classical hemophilia. Study of the Hemophilia Cooperative Group].
    Rodríguez-Moyado H; Ambriz-Fernández R; Pizzuto-Chávez J; Farfán-Canto JM; Hernández-Lugo MI; Guillén-Mariscal C; Ramírez-Ortiz G; Benítez-Aranda H
    Bol Med Hosp Infant Mex; 1986 Dec; 43(12):742-9. PubMed ID: 3101718
    [No Abstract]   [Full Text] [Related]  

  • 30. The Impact of Biotechnology on Hemophilia Care. Symposium proceedings. Cannes, France, 2-5 April 1993.
    Ann Hematol; 1994; 68 Suppl 3():S1-97. PubMed ID: 7910037
    [No Abstract]   [Full Text] [Related]  

  • 31. Lower doses of factor VIII for hemophilia.
    Penner JA; Kelly PE
    N Engl J Med; 1977 Aug; 297(7):401. PubMed ID: 876340
    [No Abstract]   [Full Text] [Related]  

  • 32. Highly purified porcine factor VIII in haemophilia A with inhibitors to factor VIII.
    Mayne EE; Madden M; Crothers IS; Ingles T
    Br Med J (Clin Res Ed); 1981 Jan; 282(6260):318. PubMed ID: 6780009
    [No Abstract]   [Full Text] [Related]  

  • 33. Porcine factor VIII therapy in patients with congenital hemophilia and inhibitors: efficacy, patient selection, and side effects.
    Hay CR; Lozier JN; Lee CA; Lafan M; Tradati H; Santagostino E; Ciavarella N; Schiavoni M; Fukui H; Yoshioka A
    Semin Hematol; 1994 Apr; 31(2 Suppl 4):20-5. PubMed ID: 7939768
    [No Abstract]   [Full Text] [Related]  

  • 34. [Prophylaxis in hemophilia].
    Ortega F; Martin-Villar J; Navarro JL
    Sangre (Barc); 1970; 15(3):355-61. PubMed ID: 5486763
    [No Abstract]   [Full Text] [Related]  

  • 35. [Therapy of hemophilia A with a cryoprecipitated antihemophilic factor].
    Ollendorff P
    Ugeskr Laeger; 1969 May; 131(20):877-81. PubMed ID: 5795169
    [No Abstract]   [Full Text] [Related]  

  • 36. Does the intensity and quality of treatment and not only the factor VIII level influence global hemostasis in patients with hemophilia A?
    Berndtsson M; Zetterberg E; Holmström M; Mahmoud Hourani Soutari N; Mikovic D; Elezovic I; Antovic JP
    Thromb Res; 2016 Aug; 144():133-5. PubMed ID: 27331346
    [No Abstract]   [Full Text] [Related]  

  • 37. Letter: Hemophilia: cyclophosphamide and factor VIII concentrate.
    Stein RS
    Ann Intern Med; 1974 Nov; 81(5):706-7. PubMed ID: 4419955
    [No Abstract]   [Full Text] [Related]  

  • 38. Use of recombinant factor VIII in the management of hemophilia.
    Mannucci PM; Gringeri A; Cattaneo M
    Curr Stud Hematol Blood Transfus; 1991; (58):46-51. PubMed ID: 1954773
    [No Abstract]   [Full Text] [Related]  

  • 39. Factor VIII inhibitors.
    Bergman GE
    Lancet; 1993 Oct; 342(8879):1109. PubMed ID: 8105322
    [No Abstract]   [Full Text] [Related]  

  • 40. Prevention of haemophilic synovitis: prophylaxis.
    Lee CA
    Haemophilia; 2007 Nov; 13 Suppl 3():20-5. PubMed ID: 17822517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.